T&R Biofab Co., Ltd.

Research T&R Biofab Co., Ltd. (246710.KQ) on Bullrun: market cap KRW 96.56B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 96.56B.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 96.56Bn/an/an/a

Dividend history

About T&R Biofab Co., Ltd.

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is T&R Biofab Co., Ltd.'s market cap?

T&R Biofab Co., Ltd.'s market capitalization is KRW 96.56B.

What does T&R Biofab Co., Ltd. do?

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea.